121050-04-2

Basic information

• Product Name: CIS-AZETIDINE-2,4-DICARBOXYLIC ACID
• Synonyms: CIS-AZETIDINE-2,4-DICARBOXYLIC ACID;C-ADA;(+/-)-TRANS-AZETIDINEN-2,4-DICARBOXYLIC ACID;CIS-AZETIDINE-2,4-DICARBOXYLIC ACID NMDA GLUTAMATE RECEPT;2,4-Azetidinedicarboxylicacid,(2R,4S)-rel-(9CI);(±)-cis-Azetidine-2,4-dicarboxylic acid,98%;2,4-Azetidinedicarboxylicacid;(§1)-cis-Azetidine-2,4-dicarboxylic acid, 98%
• CAS NO: 121050-04-2
• Molecular Formula: C₅H₇NO₄
• Molecular Weight: 145.11
• Product Categories: CARBOXYLICACID
• Mol File: 121050-04-2.mol
• Article Data: 3

Chemical Properties

• Melting Point: 259-260 °C
• Boiling Point: 264.2°C (rough estimate)
• Flash Point: 167 °C
• Appearance: white/solid
• Density: 1.5047 (rough estimate)
• Refractive Index: 1.4320 (estimate)
• Storage Temp.: 0-6°C
• Solubility: H2O: 7.5 mg/mL
• CAS DataBase Reference: CIS-AZETIDINE-2,4-DICARBOXYLIC ACID(CAS DataBase Reference)
• NIST Chemistry Reference: CIS-AZETIDINE-2,4-DICARBOXYLIC ACID(121050-04-2)
• EPA Substance Registry System: CIS-AZETIDINE-2,4-DICARBOXYLIC ACID(121050-04-2)

Safety Data

• Hazard Codes: Xi
• Statements: 36/37/38
• Safety Statements: 26-36
• WGK Germany: 3
• Hazardous Substances Data: 121050-04-2(Hazardous Substances Data)

Usage

Chemical Properties

white to off-white solid

Upstream product

• 121050-01-9 2,4-dibromoglutaric acid dibenzyl ester 
• 3479-80-9 α,α'-dibromoglutaric acid 
• 121050-02-0 (±)-trans-dibenzyl 2,2'-(1-benzylazetidine-2,4-diyl)diacetate 
• 121050-10-0 (2S,4R)-1-Benzyl-4-methylselanylcarbonyl-azetidine-2-carboxylic acid benzyl ester 
• 121050-02-0 cis-1-benzylazetidine-2,4-dicarboxylic acid dibenzyl ester 

Relevant articles and documents

Azetidine derivatives to treat memory and learning disorders

This invention relates to novel azetidines and derivatives thereof, as well as to pharmaceutical compositions and methods of treating memory and learning disorders. Another aspect of the invention relates to a method of utilizing the compounds and composi

Azetidine derivatives, compositions and methods of treating

This invention relates to novel azetidines and derivative thereof, as well as to pharmaceutical compositions and methods of treating memory and learning disorders. Another aspect of the invention relates to a method of utilizing the compounds and compositions as biological tools and materials for characterizing excitatory amino acid receptor systems. A further aspect of the invention relates to a method of treating PCP toxicity and abuse.